FPFS
ACAD icon

First Personal Financial Services’s Acadia Pharmaceuticals ACAD Stock Holding History

First Personal Financial Services’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$93 Buy
+6
New +$100 ﹤0.01% 543
2017
Q3 		– Sell
-1
Closed – – 823
2017
Q2 		$0 Hold
1
– – ﹤0.01% 854
2017
Q1 		$0 Hold
1
– – ﹤0.01% 865
2016
Q4 		$0 Sell
1
-10
-91% -$265 ﹤0.01% 912
2016
Q3 		$0 Hold
11
– – ﹤0.01% 795
2016
Q2 		$0 Buy
+11
New +$368 ﹤0.01% 806

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

First Personal Financial Services's ACAD Position: Q3 2024 in Review

First Personal Financial Services opened a new position in Acadia Pharmaceuticals (ACAD) in Q3 2024: 6 shares worth $93. The stake represents ﹤0.01% of the portfolio and ranks #543 among its holdings. This is a return to the name: First Personal Financial Services previously reported a position in ACAD as recently as Q2 2017.

First Personal Financial Services first reported a position in ACAD in Q2 2016 and has held it in 6 quarters since. 256 funds tracked by Wall St. Rank hold ACAD as of Q3 2024.

  • First Personal Financial Services held 6 shares of Acadia Pharmaceuticals worth $93 as of Q3 2024.
  • Acadia Pharmaceuticals was a new First Personal Financial Services position in Q3 2024.
  • Acadia Pharmaceuticals made up ﹤0.01% of First Personal Financial Services's portfolio in Q3 2024, its #543 holding.
  • First Personal Financial Services first reported a position in Acadia Pharmaceuticals in Q2 2016 and has held it in 6 quarters since.
  • 256 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2024.

Based on First Personal Financial Services's 13F filing for Q3 2024, filed 1 Nov 2024.